Table 1.
Demographic data of study participants in the antibody response study.
| Study participants (n = 101) | |
|---|---|
| Sex | |
| Male | 60 (59.4 %) |
| Female | 41 (40.6 %) |
| Age at vaccination (y) | 47.7 ± 18.86 |
| Age group | |
| <40 y | 46 (45.5 %) |
| ≥40 y | 55 (54.5 %) |
| BMI group | |
| <25 (non-obese) | 59 (58.5 %) |
| 25–29.99 (obesity class I) | 30 (29.7 %) |
| ≥30 (obesity class II) | 12 (11.9 %) |
| Smoking | |
| Non-smoker | 90 (89.1 %) |
| Active or previous smoker | 11 (10.9 %) |
| Blood pressure | |
| Non-hypertension | 77 (76.3 %) |
| Hypertension (≥140/90) | 24 (23.7 %) |
| Co-morbidities | |
| Diabetes mellitus | 18 (17.8 %) |
| Cardiovascular disease | 12 (11.9 %) |
| Allergic diseases | 40 (39.6 %) |
| Lung disease/asthma | 9 (8.9 %) |
| Chronic kidney disease | 0 |
| Cancer | 3 (3 %) |
| Liver diseases | 0 |
| Autoimmune disease | 0 |
BMI, body mass index.